Diabetic testing supplies, pimc
Ended Awarded Last action
- Contract number
- 75H71221F28001
- Awardee
-
Roche Diabetes Care Inc. UEI F6JDDN8L9JM4
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $250,000
Award facts
- Contract value 124% obligated
- $201,132.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Phoenix, AZ 85016, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diabetes Care Inc. received a $201,132 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Indian Health Service (IHS) on September 23, 2021, for the supply of diabetic testing supplies to the Phoenix Indian Medical Center (PIMC) in Phoenix, Arizona. This contract, which concluded on September 26, 2022, was awarded without a set-aside designation, indicating open competition. The award falls under the General Services Administration's In-vitro Diagnostics, Reagents, and Test (FSS-65-VII) Federal Supply Schedule and represents one component of Roche's larger BPA vehicle with IHS valued at $2 million through September 2026.
Roche Diabetes Care Inc., a for-profit manufacturer headquartered in Indianapolis, Indiana, specializes in diabetes management products and medical diagnostics. The company serves as a primary supplier of critical diabetes care consumables, including blood glucose monitors, test strips, lancets, and control solutions, to federal healthcare agencies with emphasis on serving American Indian and Alaska Native communities. This contract aligns with IHS's mission to provide comprehensive healthcare services to tribal populations and reflects Roche's established role as a trusted federal supplier of in-vitro diagnostic testing materials.
Quick answers
Who was awarded contract 75H71221F28001?
75H71221F28001 was awarded to Roche Diabetes Care Inc. by Indian Health Service (Department of Health and Human Services) on September 23, 2021.
How much is contract 75H71221F28001 worth?
The government has obligated $250,000 on 75H71221F28001. Its current value, with exercised options, is $201,132.
Is contract 75H71221F28001 an order under another contract?
Yes. 75H71221F28001 is a BPA call under V797D50597-75H71221A00014, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75H71221F28001 competed?
The extent of competition for 75H71221F28001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award